The oncogenic property of MSANTD3 is unclear but is supported by the fulminant course case with selective MSANTD3 gain. Collectively, MSANTD3 is the first recurrent genetic USCAP 107TH ANNUAL MEETING GEARED TO LEARN ABSTRACTS 470 aberration reported in salivary gland AciCC and adds another ...
Roswell Park Cancer Institute, Buffalo, NY. Background: We designed a targeted sequencing NGS assay that includes all all genes for testing in My Cancer Genome. To address the inherent problem of minimizing false positive calls while optimizing sensitivity we used two different NGS methodologies, ...